The use of tocolytic drugs in cases of threatened premature birth after 30 weeks of pregnancy does not improve the baby’s health.
Judge rejects Novo Nordisk’s IRA case as pricing negotiations conclude
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS